ArticleCell transplantation

Short-course blinatumomab as a bridge-to-transplantation improves the survival of Ph-negative MRD-positive B-ALL.

Xia Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.